StonvexLoading…
StonvexStonvexStonvexCore line items from FTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.93B | $9.08B | $7.82B | $6.70B |
Operating Income | $1.44B | $1.16B | $658.20M | $375.90M |
Net Income | $963.90M | $842.90M | $56.20M | $-107.20M |
EPS (Diluted) | $2.30 | $1.91 | $0.12 | $-0.24 |
Total Assets | $10.12B | $9.87B | $9.66B | $9.44B |
Total Liabilities | $6.71B | $6.73B | $6.48B | $6.17B |
Cash & Equivalents | $1.03B | $1.16B | $951.70M | $1.06B |
Free Cash Flow OCF − CapEx | $1.45B | $679.40M | $467.80M | $194.20M |
Shares Outstanding | 400.70M | 423.00M | 432.90M | 442.20M |